Designed for teams and genetics departments, Face2Gene streamlines case and workflow management
NEW YORK, May 28, 2015 /PRNewswire/ –FDNA® the pioneer in computer-aided dysmorphology analysis will launch Face2Gene Team Edition at the European Society of Human Genetics conference in Glasgow, Scotland on June 6-9, 2015. This newest addition to the Face2Gene family, powered by FDNA (Facial Dysmorphology Novel Analysis) technology, enables geneticists’ teams to share information and leverage the team’s cumulative knowledge. Face2Gene® facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date genetic references.
Face2Gene is now also available on PC, Mac and mobile devices facilitating daily use of physicians in their clinical practices. “Using Face2Gene to reference all my department’s cases, share information with my colleagues and to quickly look up relevant information in the London Medical Databases Online saves me hours of work every week and allows me to focus on my patients.” said Assoc. Prof. Ibrahim Akalin, MD, Medical Geneticist from the Istanbul Medeniyet University in Turkey. Dr. Akalin, together with Dr. Sarenur Yilmaz, has conducted research with Face2Gene and will be presenting their findings during the ESHG 2015 meeting in Glasgow.
Multi-platform availability for PC, Mac and Mobile devices enables access to Face2Gene anywhere, anytime and now, also through any device
New York, NY (PRNewswire) March 25, 2015 – FDNA®, the pioneer in computer-aided dysmorphology analysis, has released today version 4 of Face2Gene, allowing geneticists around the globe to access Facial Dysmorphology Novel Analysis from computers, as well as mobile devices. Face2Gene® facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date genetic references. The date of the release coincides with the Annual Clinical Genetics Meeting, ACMG 2015, in Salt Lake City, UT, where attendees can experience FDNA’s new offering at booth #811.
“I am excited to be a part of the FDNA community, promoting broad information sharing with my peers to amplify the scientific and clinical value of our community’s accumulated knowledge for the purpose of efficiently diagnosing individuals with rare genetic disorders.“ said Dr. Karen W. Gripp. Chief, Division of Medical Genetics, A.I. DuPont Hospital for Children.
This new version of Face2Gene also incorporates the much-anticipated Online Unknown Forum dedicated to the discussion and review of undiagnosed and challenging cases. FDNA will unveil this forum in a theater presentation during ACMG 2015 on Thursday March 26th, 2015 at 11:40 am.
“We are excited to allow access to Face2Gene from all devices and showcase our technology at this prestigious venue. This fourth version of Face2Gene demonstrates our commitment to the community of genetics professionals. We will continue to work diligently to improve and add new features to Face2Gene,” said Dekel Gelbman, FDNA’s Chief Executive Office
Face2Gene® is a search and reference tool powered by the Facial Dysmorphology Novel Analysis Technology
New York, NY (PRNewswire) March 12, 2015 – FDNA, the pioneer in computer-aided dysmorphology analysis , has announced today the launch of an online forum for the genetics expert community dedicated to the discussion and review of undiagnosed and challenging cases . The company will unveil the online forum in a scheduled theater presentation at the Annual Clinical Genetics Meeting ACMG 2015 in Salt Lake City, UT on March 26th, 2015 at 11:40 am.
Face2Gene facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date genetic references. One of the unmet needs raised by Face2Gene users worldwide is the need to consult with their peers in the genetics community about certain cases. Some of the cases they encounter have genetic syndromes that are so rare, that only the cumulative knowledge and experience of the larger geneticist community can lead to a diagnosis.